Ethiopia Launches Programmatic Introduction of the 6-Month BPaLM/BPaL Regimen for RR/DR-TB Treatment
Ethiopia has officially launched the programmatic rollout of the 6-month Bedaquiline, Pretomanid, Linezolid, and Moxifloxacin (BPaLM) regimen for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis. The national launching event took place in Bishoftu with the presence of officials from the Ministry of Health, Regional State Health Bureau TB program managers, key […]